Regenerative IV drip bag with DRIPDOK branding - Deep purple clinical stacks therapy Bali

Regenerative IV Therapy Bali | Clinical Stacks



Regenerative IV Therapy Bali | Clinical Stacks

DRIPDOK’S REGENERATIVE IV STACKS ARE HIGH-DOSE, CLINICALLY TARGETED INFUSION PROTOCOLS FORMULATED FOR FOUR DISTINCT PHYSIOLOGICAL SYSTEMS. NEURORESTORE™: NAD+, METHYLENE BLUE, Nootropic Cofactor C-14, AND Neurological Cofactor B12-MX FOR NEUROPLASTICITY AND MITOCHONDRIAL RESTORATION. REPAIRMAX™: GROWTH FACTORS, HIGH-DOSE VITAMIN C, ZINC, AND AMINO ACID COMPLEX FOR ACCELERATED MUSCULOSKELETAL REPAIR. MITOCORE™: COENZYME Q10 PRECURSORS, ALA, NAD+, AND CARNITINE FOR MITOCHONDRIAL ELECTRON TRANSPORT CHAIN SUPPORT. IMMUNEPRIME™: HIGH-DOSE ASCORBATE, SELENIUM, GLUTATHIONE, AND Immunopeptide Complex TA-17 FOR IMMUNE SYSTEM RESET.

Each regenerative stack is administered as a 90–120 minute IV infusion by a registered nurse at your Bali location. Physician intake required prior to first session to assess therapeutic objectives, contraindications, and stack selection. Protocols can be combined across sessions and integrated with peptide, NAD+ standalone, or ozone protocols for a full regenerative programme.

All compounding is performed under USP 797 standards. Cold-chain logistics maintained from pharmacy to administration. Advance booking of 24–48 hours required. Available across all Bali areas including Seminyak, Canggu, Ubud, Uluwatu, and Sanur.

Session at a Glance

mL

Infusion Volume
500 mL stacks

IV

Administration
Intravenous Drip

min

Infusion Duration
90–120 Minutes

RN

Administered By
Registered Nurse

Rx

Session Frequency
Variable

24h

Advance Notice
24–48 Hours

MD

Oversight
Physician-Reviewed

SVC

Delivery Model
At-Home Concierge

From $265 USD

REGENERATIVE IV PROTOCOL

NeuroRestore IV Bali | Regenerative IV Therapy · Clinical Stack

A multi-compound regenerative IV protocol combining advanced neuroprotective agents, mitochondrial cofactors, and cellular repair substrates. Physician-reviewed, nurse-administered, delivered to your location across Bali.

500 mL stacks

Infusion volume per session

100%

Bioavailability via IV delivery

90–120 min

Typical session duration

REGENERATIVE PEPTIDE PROTOCOL

Physician-Assigned Stack · Biomarker-Ordered

Each component is selected for physiological relevance and enzymatic function — not marketing appeal.

NA-Sx

BDNF Peptide Complex A2 (BDNF Upregulation)

BDNF Peptide Complex A2 (BBB-permeable) upregulates BDNF and NGF synthesis — the neurotrophic factors responsible for neuronal survival, synaptic plasticity, and cognitive recovery. Originally developed for stroke and TBI rehabilitation. HPA axis normalisation reported within 24–72 hours post-infusion.

CDP

Nootropic Cofactor C-14 (Neuroprotection · CDP-Choline)

Nootropic Cofactor C-14 (CDP-Choline) provides both choline for acetylcholine synthesis and cytidine for UTP and phospholipid membrane production. Neuroprotective at the phospholipid level — supports myelin integrity, synaptic membrane repair, and dopaminergic neurotransmitter function.

BPC

Regenerative Polypeptide RP-34 (Systemic Tissue Repair)

Regenerative Polypeptide RP-34 (Body Protective Compound) demonstrates systemic healing activity — tendon, gut, connective tissue, and neural repair — via upregulation of growth hormone receptor signalling and nitric oxide modulation. Stable IV-grade peptide, USP 797 compounded at Dripdok.

TB4

Cytoskeletal Polypeptide TP-500 (Immunopeptide Complex TA-17 B4 Fragment)

Cytoskeletal Polypeptide TP-500 (Immunopeptide Complex TA-17 fragment) promotes vascular endothelial cell migration, collagen deposition, and cardiac tissue repair. Synergistic with Regenerative Polypeptide RP-34 — the two peptides address complementary repair mechanisms at the cellular and extracellular matrix level.

GHK

Copper Polypeptide Complex GH-09 (Collagen & Neural Remodelling)

Copper Polypeptide Complex GH-09 (copper tripeptide) stimulates collagen and glycosaminoglycan synthesis, modulates metalloproteinase activity, and activates wound healing gene expression. Acts as a neuroregenerative agent at IV concentrations — supports neural remodelling and anti-inflammatory signalling.

GSH

Glutathione (Antioxidant · Neuroprotection)

Glutathione (600mg) provides systemic antioxidant support and neuroprotection during the infusion. Maintains a reduced intracellular environment that favours growth factor signalling and mitochondrial function — co-administered with all Regen IV protocols.

CLINICAL BENEFITS

Targeted Cellular Mechanisms

The NeuroRestore Regenerative IV protocol layers clinically validated compounds to address neurological decline, mitochondrial dysfunction, and cellular oxidative damage simultaneously. This is a physician-coordinated protocol — not a menu selection — designed for individuals requiring systemic regenerative intervention.

01

BDNF Upregulation & Neurotrophin Axis

BDNF Peptide Complex A2 and Nootropic Cofactor C-14 synergistically upregulate BDNF and NGF synthesis within 24–72 hours post-infusion. BDNF modulates synaptic LTP (long-term potentiation), dendritic complexity, and neuronal survival — directly measurable via cognitive performance and HRV markers in some protocols.

02

Systemic Tissue Repair & Regeneration

Regenerative Polypeptide RP-34 and Copper Polypeptide Complex GH-09 activate tissue repair pathways across tendon, gut, neural, and connective tissue. Collagen synthesis is upregulated via TGF-β and metalloproteinase modulation. Copper Polypeptide Complex GH-09 alone has demonstrated anti-fibrotic, pro-angiogenic, and wound-healing activity across multiple tissue types.

03

HPA Axis Regulation & Burnout Recovery

BDNF Peptide Complex A2 modulates the HPA (hypothalamic-pituitary-adrenal) axis — reducing CRH hypersecretion patterns associated with burnout, chronic stress, and post-viral adrenal fatigue. Combined with NAD+ base support, the protocol targets cortisol dysregulation at the neuroendocrine level.

04

Immune Reconstitution & Anti-Inflammation

Immunopeptide Complex TA-17 (in ImmunePrime stack) upregulates natural killer cell activity and T-cell differentiation — directly addressing impaired innate immunity in post-viral recovery, autoimmune modulation, and chronic infection patterns. Copper Polypeptide Complex GH-09 provides complementary anti-inflammatory signalling.

PROTOCOL COORDINATION

How Each Session is Confirmed

01

Select Date, Time & Service

Submit your preferred service, date, and time. Your Patient Relations (PR) coordinator reviews availability and logistics — PR handles operational scheduling, not clinical decisions.

02

Secure Payment & Intake Form

A payment link is sent via Wise, Stripe, or local transfer. Advance payment is required to confirm the booking. Upon payment, you receive a patient consent and medical intake form to complete.

03

Physician Review & Confirmation

Your physician reviews the intake form for clinical suitability and safety. Once approved, your appointment is formally confirmed. Standard protocols require 24–48 hours advance notice for nurse scheduling and cold-chain preparation.

Begin Your Protocol

Physician-reviewed IV therapy, delivered to your location across Bali. Your Patient Relations team coordinates scheduling, payment, and confirmation. Standard protocols require 24–48 hours advance notice. Request your session below.

Begin Your NeuroRestore Protocol

Physician-guided regenerative IV therapy, delivered to your door. Available across Bali — Canggu, Seminyak, Ubud, Kuta, Nusa Dua, and surrounding areas. Extended infusion requires 48 hours advance booking.

AT-HOME IV THERAPY — BALI

NeuroRestore Regenerative IV

Multi-compound regenerative infusion targeting neuroprotection, mitochondrial repair, and cellular recovery. Physician-reviewed, nurse-administered, delivered to your location across Bali.

THE SCIENCE

Neuroprotection & Regenerative Cellular Repair

The NeuroRestore protocol combines compounds targeting distinct but complementary regenerative pathways: mitochondrial complex restoration, neuroinflammation reduction, oxidative damage clearance, and neurotrophic support. Intravenous delivery achieves systemic concentrations that oral delivery cannot replicate for lipophilic and large-molecule components. Each protocol stack is physician-designed based on clinical indication, ensuring compound compatibility and appropriate dosage sequencing.

WHAT'S INSIDE

NeuroRestore Protocol Composition

Protocol Base

0.9% Normal Saline (500 mL) · pH-controlled isotonic base · B-complex Soluvit included · Osmolality-verified per USP 797 · Myers base co-administered with every stack protocol

Regenerative Peptide Stack

Physician-assigned from: BDNF Peptide Complex A2 + Nootropic Cofactor C-14 + B12 + Glutathione (NeuroRestore) · Regenerative Polypeptide RP-34 + Cytoskeletal Polypeptide TP-500 + Copper Polypeptide Complex GH-09 (RepairMax) · Mitopeptide Complex MT-21 + Mitochondrial Polypeptide MT-33 + Copper Polypeptide Complex GH-09 (AntiAge) · Immunopeptide Complex TA-17 + Copper Polypeptide Complex GH-09 + Glutathione (ImmunePrime) · Protocol determined at intake

Adjunctive Cofactors

Alpha-Lipoic Acid · Magnesium Sulphate · Glutathione 600mg · Nootropic Cofactor C-14 · B12 (Hydroxocobalamin) · Component selection varies by protocol and biomarker data — all compounded fresh per session under USP 797 laminar flow

Component concentrations are clinically determined by protocol. Physician review is required prior to every session. Formulations may be adjusted based on individual intake assessment.

CLINICAL DATA

Clinical Response Consistency by Mechanism

The NeuroRestore IV protocol targets four independent biological mechanisms. The chart below reflects response consistency levels reported in published clinical and research literature — not a guarantee of individual outcomes.

Neurotrophic support (BDNF pathway) Consistent
Oxidative stress reduction High
Neuroinflammation modulation High
Mitochondrial biogenesis support Moderate–High
Post-viral fatigue recovery support Emerging
Consistent / High (≥80%)
Moderate–High (60–80%)
Emerging (<60%)

Directional representation based on published literature. Not a clinical trial result. Individual outcomes vary.

INSIGHT

Brain-derived neurotrophic factor doesn't increase linearly with intervention — it responds in time-gated windows, and the first 24–72 hours after certain IV protocols appear to be the most clinically significant.

Recent research published in a major neuroscience journal identified that BDNF upregulation — the process by which the brain strengthens synaptic plasticity, promotes neuronal survival, and supports executive function — is not a steady-state process. It occurs in sensitive windows triggered by specific stimuli, after which gene expression returns to baseline regardless of continued exposure.

The clinical implication is protocol timing. Delivering the right substrates at the right phase — particularly in the context of recovery from neurological stress, post-viral fatigue, or accumulated cognitive load — may be meaningfully more effective than continuous low-level supplementation. This is one reason IV administration is considered more than a route question; it is a timing question.

CLINICAL INDICATION

Protocol Suitability

01

Neurological Recovery & Post-Viral Rehabilitation. Individuals recovering from viral neurological sequelae, including cognitive decline, persistent fatigue, and autonomic dysregulation. The protocol targets neuroinflammation reduction, mitochondrial reactivation, and neurotrophic support via physician-selected compound stacking.

02

Advanced Longevity & Biological Optimisation. Those pursuing diagnostics-informed cellular repair beyond foundational vitamin protocols. Typically indicated after a Myers Cocktail baseline has been established. Physician assessment required to confirm regenerative readiness and compound sequencing.

03

High-Performance Recovery & Elite Athletic Protocols. Athletes and performance-focused individuals requiring accelerated tissue repair, neuroprotective support, and mitochondrial regeneration between intensive training cycles. Extended infusion duration reflects compound complexity — physician scheduling required.

CLINICAL OUTCOMES

Observed Treatment Responses

Neurological Recovery & Brain Function

Clinically observed improvements in cognitive processing speed, memory consolidation, and neurological fatigue — supported by multi-pathway neuroprotective mechanisms including neuroinflammation reduction and mitochondrial energy restoration in CNS tissue.

Mitochondrial Repair & Cellular Energy

Regenerative cofactor repletion restores mitochondrial complex I–IV function and electron transport chain efficiency. Reported outcomes include sustained physical energy restoration, improved exercise tolerance, and resolution of post-exertional fatigue — without stimulant dependency.

Oxidative Stress Reduction & Systemic Recovery

High-dose antioxidant compounds delivered intravenously neutralise accumulated reactive oxygen species (ROS) contributing to cellular ageing and tissue degradation. Supports immune normalisation, inflammatory marker reduction, and physiological resilience. Individual outcomes vary based on clinical baseline and protocol frequency.

Clinical outcomes are individual and may vary based on baseline nutritional status, health history, and protocol frequency. These are reported observations, not therapeutic guarantees. This protocol does not constitute medical treatment for any specific condition. All sessions are physician-reviewed for safety and clinical appropriateness prior to confirmation.

PROTOCOL DESIGN

Build a Comprehensive Recovery Stack

NeuroRestore IV addresses the biochemical environment of recovery. Pair it with protocols that target cell-to-cell communication, energy metabolism, or foundational micronutrient status for a complete approach.

UPGRADE YOUR PROTOCOL

Exosome Therapy

NeuroRestore IV prepares the biochemical environment. Exosome therapy amplifies the recovery signal at the cellular level through exosomal miRNA cargo — addressing tissue remodelling and regenerative signalling simultaneously. Together they cover different mechanistic layers of the same recovery process.

View Exosome Therapy

PAIR WITH

NAD⁺ & NMN IV

Recovery at the cellular level requires adequate energy currency. NAD⁺ IV restores the coenzyme central to mitochondrial function and sirtuin activation — creating the metabolic foundation that allows NeuroRestore's mechanisms to operate with full effect.

Explore NAD⁺ IV

STARTING POINT

Myers Cocktail IV

If you're new to clinical IV therapy or want to establish a micronutrient baseline before a targeted protocol, the Myers Cocktail provides comprehensive foundational support. Many clients begin here and progress to NeuroRestore once their baseline status is established.

Start With Myers
WHY DRIPDOK

A Physician-Founded System. Not an IV Menu.

DripDok was established in 2017 by a US-trained physician with academic foundations in molecular genetics, analytical chemistry, and biotechnology — and is associated with research through Purdue, Harvard, MIT, and Michigan State University. As the first clinic in Southeast Asia to offer advanced NAD+ IV protocols, DripDok operates as a precision medicine system, not a retail infusion bar. Every protocol is governed by diagnostic-first methodology, cold-chain sourcing standards, and formal physician oversight — applied to every client, every session.

PERSONALISED PROTOCOL

Complex History? Dr. Close Reviews Every Case Directly.

NeuroRestore IV is a multi-mechanism protocol. For some patients — particularly those with post-viral neurological fatigue, long-term cognitive decline, or complex medical histories — the standard protocol may benefit from adjustment. Dr. Close reviews all intake data personally to determine whether modifications to session frequency, volume, or adjunctive support are appropriate.

Have you experienced neurological symptoms, cognitive decline, or persistent fatigue following a viral illness?
Wearable data showing prolonged HRV suppression, autonomic dysregulation, or impaired recovery capacity?
Neuroimaging, neurocognitive assessments, or specialist reports documenting cognitive or functional changes?
A history of traumatic brain injury, chronic inflammatory conditions, or metabolic illness?
Prior IV therapy or treatment protocols that produced partial or unexpected responses?
APPLY FOR A PROTOCOL CONSULTATION

Dr. Close reviews all intake forms personally. Consultations are conducted via teleconsult or in person in Bali.

BEGIN YOUR PROTOCOL

How to Book a Session

Your Patient Relations team coordinator reviews your request and sends a secure payment link via Wise, Stripe, or local transfer. After payment, you complete a medical intake and consent form. Your physician reviews it for clinical suitability, then confirms your appointment. Standard protocols require 24–48 hours advance notice for nurse scheduling and cold-chain preparation.

We’ll reply when possible. Please follow instructions when prompted.
P
Open chat